Platelet proteomics profiling in transfusion adverse events

被引：0
|
作者：
Aloui, C. [1 ]
Chakroun, T. [1 ]
Claverol, S. [2 ]
Fagan, J. [3 ]
Benamara, H. [4 ]
Mounier, C. [5 ]
Cognasse, F. [3 ]
Garraud, O. [6 ]
Laradi, S. [3 ]
机构：
[1] Univ Lyon, GIMAP, EA 3064, St Etienne, France
[2] Univ Bordeaux Segalen, Proteome Platform, CGFB, Bordeaux, France
[3] EFS Rhone Alpes Auvergne, Res Dept, St Etienne, France
[4] EFS Rhone Alpes Auvergne, Preparat Dept, St Etienne, France
[5] Cancerol Inst Lucien Neuwirth, St Etienne, France
[6] Natl Inst Blood Transfus INTS, Paris, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2016年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PLA16
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [1] PLATELET PROTEOMICS PROFILING IN TRANSFUSION ADVERSE EVENTS
    Aloui, C.
    Barlier, C.
    Claverol, S.
    Fagan, J.
    Benamara, H.
    Tavernier, E.
    Cognasse, F.
    Garraud, O.
    Laradi, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 723 - 724
  • [2] Transfusion-related adverse events in the Platelet Dose study
    Kaufman, Richard M.
    Assmann, Susan F.
    Triulzi, Darrell J.
    Strauss, Ronald G.
    Ness, Paul
    Granger, Suzanne
    Slichter, Sherrill J.
    TRANSFUSION, 2015, 55 (01) : 144 - 153
  • [3] Platelet Concentrates - Indication, Informed Consent, Transfusion and Adverse Events
    Mueller, Markus M.
    Lehmann, Maximilian
    Neef, Vanessa
    Zacharowski, Kai
    Tonn, Torsten
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2025, 60 (01): : 35 - 51
  • [4] Efficacy and adverse events of platelet transfusion - Product-specific differences
    Hellstern, Peter
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2008, 35 (02) : 102 - 105
  • [5] Platelet transfusion and adverse outcomes
    Vamvakas, EC
    LANCET, 2004, 364 (9447): : 1736 - 1738
  • [6] Whole platelet transcriptome profiling confirms a cytoskeleton remodeling in platelet components associated with adverse transfusion reactions
    Awounou, D.
    Barlier, C.
    Aloui, C.
    Fagan, J.
    Salin, F.
    Boury, C.
    Lesur, I.
    Mounier, C.
    Tavernier, E.
    Cognasse, F.
    Garraud, O.
    Sandrine, L.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1714 - 1714
  • [7] Transfusion Reactions and Adverse Events
    Abdallah, Rim
    Rai, Herleen
    Panch, Sandhya R.
    CLINICS IN LABORATORY MEDICINE, 2021, 41 (04) : 669 - 696
  • [8] Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling
    Shimada, Yuichi J.
    Raita, Yoshihiko
    Liang, Lusha W.
    Maurer, Mathew S.
    Hasegawa, Kohei
    Fifer, Michael A.
    Reilly, Muredach P.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2022, 15 (06): : 560 - 569
  • [9] Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling
    Shimada, Y. J.
    Raita, Y.
    Maurer, M. S.
    Hasegawa, K.
    Fifer, M. A.
    Reilly, M. P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1776 - 1776
  • [10] Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
    Snyder, Edward L.
    Wheeler, Allison P.
    Refaai, Majed
    Cohn, Claudia S.
    Poisson, Jessica
    Fontaine, Magali
    Sehl, Mary
    Nooka, Ajay K.
    Uhl, Lynne
    Spinella, Philip
    Fenelus, Maly
    Liles, Darla
    Coyle, Thomas
    Becker, Joanne
    Jeng, Michael
    Gehrie, Eric A.
    Spencer, Bryan R.
    Young, Pampee
    Johnson, Andrew
    O'Brien, Jennifer J.
    Schiller, Gary J.
    Roback, John D.
    Malynn, Elizabeth
    Jackups, Ronald
    Avecilla, Scott T.
    Lin, Jin-Sying
    Liu, Kathy
    Bentow, Stanley
    Peng, Ho-Lan
    Varrone, Jeanne
    Benjamin, Richard J.
    Corash, Laurence M.
    TRANSFUSION, 2022, 62 (07) : 1365 - 1376
12345